Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RS 25259

Known as: RS-25259 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

palonosetron

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Palonosetron. RS 25259, RS 25259 197.
  • Drugs in R&D
  • 1999
    • Corpus ID: 39285328
 
1998
1998
The Efficacy of RS-25259, a Long-Acting Selective 5-HT3 Receptor Antagonist, for Preventing Postoperative Nausea and Vomiting After Hysterectomy Procedures
We evaluated the safety and efficacy of RS-25259, a potent and long-acting selective 5-HT3 receptor antagonist, for the… Expand
1997
1997
A329 EFFICACY OF RS-25259, A NOVEL 5-HT SUB 3 ANTAGONIST, IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING AFTER MAJOR GYNECOLOGIC SURGERY
 
1996
1996
Oral RS-25259 prevents postoperative nausea and vomiting following laparoscopic surgery
 
Highly Cited
1995
Highly Cited
1995
The interaction of RS 25259‐197, a potent and selective antagonist, with 5‐HT3 receptors, in vitro
1 A series of isoquinolines have been identified as 5‐HT3 receptor antagonists. One of these, RS 25259‐197 [(3aS)‐2‐[(S)‐1… Expand
Highly Cited
1995
Highly Cited
1995
Pharmacological characterization of RS 25259‐197, a novel and selective 5‐HT3 receptor antagonist, in vivo
1 The pharmacological effects in vivo, of RS 25259‐197, a selective 5‐HT3 receptor antagonist, have been investigated. 2 In… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE